Humacyte, Inc. - COM (HUMA)

CUSIP: 44486Q103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
9,522,696
Share change
+2,241,069
Total reported value
$69,016,600
Put/Call ratio
36%
Price per share
$7.25
Number of holders
58
Value change
+$7,310,797
Number of buys
45
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 44486Q103?
CUSIP 44486Q103 identifies HUMA - Humacyte, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of HUMA - Humacyte, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
3/4/5
Former 10% Shareholder
class O/S missing
18,312,735
$21,792,154 26 Aug 2021
York Capital Management Global Advisors, LLC
13F
Company
class O/S missing
2,291,397
$20,590,000 30 Sep 2021
13F
ORBIMED ADVISORS LLC
13F
Company
class O/S missing
1,500,000
$17,415,000 30 Sep 2021
13F
Diameter Capital Partners LP
13F
Company
class O/S missing
954,138
$11,078,000 30 Sep 2021
13F
Monashee Investment Management LLC
13F
Company
class O/S missing
750,000
$8,708,000 30 Sep 2021
13F
CVI Holdings, LLC
13F
Company
mixed-class rows
683,850
mixed-class rows
$6,349,000 30 Sep 2021
13F
Maven Securities LTD
13F
Company
class O/S missing
500,000
$5,805,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
290,109
$3,368,000 30 Sep 2021
13F
LMR Partners LLP
13F
Company
class O/S missing
169,683
$1,970,000 30 Sep 2021
13F
LPL Financial LLC
13F
Company
mixed-class rows
144,615
mixed-class rows
$1,418,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
mixed-class rows
73,093
mixed-class rows
$842,000 30 Sep 2021
13F
HRT FINANCIAL LP
13F
Company
mixed-class rows
76,413
mixed-class rows
$418,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
30,932
$359,000 30 Sep 2021
13F
Exos Asset Management LLC
13F
Company
mixed-class rows
55,993
mixed-class rows
$327,000 30 Sep 2021
13F
Eudaimonia Partners, LLC
13F
Company
class O/S missing
25,038
$291,000 30 Sep 2021
13F
PEAK6 Investments LLC
13F
Company
class O/S missing
18,317
$213,000 30 Sep 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
18,224
$211,000 30 Sep 2021
13F
PHILADELPHIA TRUST CO
13F
Company
class O/S missing
15,000
$174,000 30 Sep 2021
13F
BROWN ADVISORY INC
13F
Company
class O/S missing
13,129
$152,000 30 Sep 2021
13F
JANE STREET GROUP, LLC
13F
Company
class O/S missing
52,282
$151,000 30 Sep 2021
13F
Sio Capital Management, LLC
13F
Company
class O/S missing
49,998
$145,000 30 Sep 2021
13F
Alpine Global Management, LLC
13F
Company
class O/S missing
47,500
$138,000 30 Sep 2021
13F
Kovitz Investment Group Partners, LLC
13F
Company
class O/S missing
11,050
$128,000 30 Sep 2021
13F
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV
13F
Company
class O/S missing
11,000
$128,000 30 Sep 2021
13F
United Asset Strategies, Inc.
13F
Company
class O/S missing
10,308
$120,000 30 Sep 2021
13F
Warberg Asset Management LLC
13F
Company
class O/S missing
35,662
$103,000 30 Sep 2021
13F
Belvedere Trading LLC
13F
Company
class O/S missing
8,671
$87,000 30 Sep 2021
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
6,262
$73,000 30 Sep 2021
13F
William Edward Tente
3/4/5
Chief Regulatory Officer
mixed-class rows
54,094
mixed-class rows
$62,498 26 Aug 2021
P SCHOENFELD ASSET MANAGEMENT LP
13F
Company
class O/S missing
19,155
$55,000 30 Sep 2021
13F
CITIGROUP INC
13F
Company
class O/S missing
4,062
$47,000 30 Sep 2021
13F
Verition Fund Management LLC
13F
Company
class O/S missing
15,000
$44,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
3,502
$40,000 30 Sep 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
2,950
$34,000 30 Sep 2021
13F
O'Dell Group, LLC
13F
Company
class O/S missing
1,500
$17,000 30 Sep 2021
13F
Sandy Spring Bank
13F
Company
class O/S missing
1,335
$15,000 30 Sep 2021
13F
Avior Wealth Management, LLC
13F
Company
class O/S missing
1,000
$11,000 30 Sep 2021
13F
Cutler Group LLC / CA
13F
Company
class O/S missing
1,000
$11,000 30 Sep 2021
13F
Jeffrey Harold Lawson
3/4/5
Chief Surgical Officer, Director
mixed-class rows
9,452
mixed-class rows
$9,374 26 Aug 2021
UBS Group AG
13F
Company
class O/S missing
778
$9,000 30 Sep 2021
13F
WOLVERINE ASSET MANAGEMENT LLC
13F
Company
class O/S missing
2,959
$8,000 30 Sep 2021
13F
Jacobi Capital Management LLC
13F
Company
class O/S missing
560
$7,000 30 Sep 2021
13F
HOWE & RUSLING INC
13F
Company
class O/S missing
200
$2,000 30 Sep 2021
13F
Kiernan Thomas DeAngelis
3/4/5
Chief Medical Officer
class O/S missing
1,575
26 Aug 2021

Institutional Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2021

As of 31 Dec 2021, Humacyte, Inc. - COM (HUMA) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,522,696 shares. The largest 10 holders included York Capital Management Global Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, Monashee Investment Management LLC, Diameter Capital Partners LP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Gladstone Institutional Advisory LLC, and UBS Group AG. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
31
Q4 2021 holders
58
Holder diff
27
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.